According to CBinsights data, the Novo Group tops the list of the most active corporate investors in the healthcare sector in terms of level of investment and number of deals. Johnson & Johnson and Novartis complete the top three.
1TP2Q1.81B of investment up 241TP1Q from previous quarter
Investment and exits in the healthcare sector made a strong comeback during 2Q13. Not only did capital invested and funded in healthcare companies reach 1.81B$ (up 24% from 1Q13) but investment in early stage companies also grew to the 5th highest quarter. In addition, IPO deals sweetened a moribund market with 11 VC-funded companies taken to IPO during 2Q13.
«Also in Spain we have seen corporate sales for very significant amounts such as Endosense by the Ysios fund. We are optimistic for the sector because a large part of the money from these sales will return to the healthcare sector financing circuit, as SODENA declared today, comments Diego Gutierrez, a corporate finance expert at ABRA INVEST.In fact, the health sector ranks second after ICTs, both in Spain and in the United States, points out Diego Gutiérrez.
Top 3: Novo Group, Johnson & Johnson and Novartis
Based on levels of M&A activity, the Denmark-based Novo Group tops the list with more than 50 investments made in health-related companies. Just behind the Novo Group are Swiss-based pharmaceutical giants Johnson & Johnson and Novartis, both of which maintain their private equity arms.
Pharmaceutical companies among the top 10 most active corporate investors across all sectors
Johnson & Johnson Development Corp. and Novartis Venture Funds rank among the 10 most active corporate venture capital investors across all sectors. Eight of the 10 are companies listed on the New York Stock Exchange. «Corporate venture capital is resurfacing »as it did during the dotcom era. The trend appears to be continuing in the second quarter of 2013, with a 40% increase in the number of CVCs that have been involved in a transaction,” notes Diego Gutierrez.